INR101 for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Apr 2025: Trial registered, NCT06922903

The trials

NCT06922903: Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

State
Not started
Phase
Phase 3
People
240 planned
Started
Apr 2025
Primary completion
May 2026
Arms
INR101 PET/ CT
Results
None posted
  1. 11 Apr 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.